The 2024 general assembly of ImmunoConcEpT took place on february 16th
Articles
Feb 2024: The flow cytometry platform new labeling
FACSility, the flow cytometry platform of the TBM Core, just obtained the labellisation from IBiSA.
Congratulations!
IBiSA is a scientific interest group founded in 2007. IBiSA leads a selective national policy of labeling and support for biology, health and agronomy platforms, as well as biological resource centers (CRB). Labeled structures can access substantial funding for investments deemed necessary for their missions. Open to the scientific community, they undertake in return to make their resources and expertise available to external teams to advance research.
IBiSA thus promotes the organization and pooling of resources and measurement means necessary for research in life sciences. The GIS also encourages the creation of steering, consultation and cooperation structures, the running of thematic networks and quality approaches.
For further information about IBiSA here.
2024 New Team1 labelisation
J Dechanet-Merville‘s team has been awarded a Team Labelisation by La Ligue Nationale Contre le Cancer for a project entitled “Activation modalities and actions of gamma-delta T cells against tumors: focus on glioblastoma” involving Myriam Capone, Coline Gentil, Selma Cornillot-Clément, Vincent Pitard and Lionel Couzi.
Congratulations Team1!
2024
ImmunoConcEpT members wish you an excellent 2024!
Les membres d’ImmunoConcEpT vous souhaitent un excellent 2024 !
Congrats to Emily Cayssials for the “Josy Reiffers” award
Emily Cayssials received a grant from the Fondation Bergonié for her research project on the role of gamma-delta T cells in Chronic Myeloid leukemia.
The prize ceremony took place at the Hotel de Region, on November 28th.
ImmunoConcEpT, by Julie Déchanet-Merville
Voir et revoir la vidéo préparée par le CNRS et diffusée lors de la cérémonie de remise de la Médaille d’Argent du CNRS à Julie Déchanet-Merville.
The CNRS silver medal honors researchers for the originality, quality and importance of their work recognized nationally and internationally. This year, Julie Déchanet-Merville is one of the 24 laureates. Congratulations boss!
15 novembre 2023: Julie Déchanet-Merville reçoit la médaille d’argent du CNRS
Chaque année le CNRS récompense les femmes et les hommes qui ont le plus contribué au rayonnement, à l’avancée et à l’accompagnement de la recherche. Cette année Julie Déchanet-Merville est une des 24 lauréates et lauréats de la médaille d’argent du CNRS 2023 qui distingue des chercheuses et des chercheurs pour l’originalité, la qualité et l’importance de leurs travaux, reconnus sur le plan national et international. Félicitations !
The CNRS silver medal honors researchers for the originality, quality and importance of their work recognized nationally and internationally. This year, Julie Déchanet-Merville is one of the 24 laureates. Congratulations boss!
Come and check out the seminar of Mathilde Pohin
We are delighted to welcome Mathilde Pohin, who is a research scientist at the Kennedy Institute of Rheumatology in Oxford, UK. She works in the laboratory of Pr. Fiona Powrie on the mechanisms of inflammatory bowel disease patient’s resistance to therapy.
Here is the abstract of her presentation: The complex multifactorial nature of Inflammatory Bowel Disease (IBD) and heterogeneous clinical phenotypes restrains our ability to target biological therapies to those most likely to benefit. A roadblock to targeted therapy in IBD is patient stratification. To date patient stratification is limited to clinical symptoms and phenotype (Crohn’s Disease, Ulcerative Colitis) which shows only moderate differences in transcriptomic signatures and cellular composition. The use of unsupervised clustering of ‘omic and cellular signatures is now recognised as a promising option to overcome this challenge. We applied this approach in IBD by integrating bulk RNA-sequencing network-based discovery analysis with single cell transcriptomics and investigation of molecular pathology to identify and define distinct tissular responses termed ‘pathotypes’. Such pathotypes represent a new way to stratify patients based on distinct intestinal tissue ecologies which involve the remodelling of tissue resident stromal cell populations and the activation of innate and adaptive immune cell compartments. Our study demonstrates the feasibility of identifying pathotypes and their association with response to therapy. We are now building on this work to create an atlas of IBD pathotypes and perform mechanistic analyse to identify underlying pathophysiological mechanisms and identifying which biological therapies are most likely to benefit each pathotypes.
“Hot news”:
More informations about the award: https://www.frm.org/nos-publications/portraits-de-chercheurs/patrick-blanco
18/11 : Journée “grand public” du département SBM
Page Facebook de l’événement: https://fb.me/e/fV45CFrh0
Le Département Sciences Biologiques et Médicales organise sa 1ère Journée Grand Public.
Le bâtiment BBS (Bordeaux Biologie Santé) vous ouvre ses portes : venez discuter avec les chercheurs, participer à des ateliers, découvrir les laboratoires de recherche.